Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 10 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 7 Uterine Cervical Neoplasms 5 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Retinoblastoma 1 Radiation Injuries 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Genital Neoplasms, Female 1 Endometrial Neoplasms 1 Breast Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Brachytherapy × Clear all

NCT01255748 2025-09-09

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

40,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡